Redox modulation of STIM-ORAI signaling  by Bhardwaj, Rajesh et al.
RR
R
a
b
a
A
R
A
A
K
S
O
C
S
R
H
R
C
N
h
0
0Cell Calcium 60 (2016) 142–152
Contents lists available at ScienceDirect
Cell  Calcium
jou rn al hom epage: www.elsev ier .com/ locate /ceca
eview
edox  modulation  of  STIM-ORAI  signaling
ajesh  Bhardwaja,∗∗, Matthias  A.  Hedigera,  Nicolas  Demaurexb,∗
Institute of Biochemistry and Molecular Medicine, University of Bern, Bühlstrasse 28, CH-3012 Bern, Switzerland
Department of Cell Physiology and Metabolism, University of Geneva, 1 rue Michel-Servet CH-1211 Geneva 4, Switzerland
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 1 March 2016
ccepted 8 March 2016
vailable online 19 March 2016
eywords:
TIM
a  b  s  t  r  a  c  t
STIM1  and ORAI1  constitute  the  core machinery  of  the ubiquitous  store-operated  calcium  entry  pathway
and  loss of  function  in these  proteins  is  associated  with  severe  immune  and  muscular  disorders.  Other
isoforms—STIM1L,  STIM2,  ORAI2  and  ORAI3  exhibit  varied  expression  levels  in  different  cell types  along
with  several  other  interaction  partners  and  thereby  play different  roles  to facilitate,  regulate  and  ﬁne-
tune  the  calcium  entry.  STIM  proteins  convey  the  Ca2+ store-depletion  message  to  the  PM  and  thereby
participate  in  reﬁlling  of  the ER  by physically  interacting  with  the  Ca2+-selective  ORAI channels  at  the  PM.RAI
RAC
tore-operated calcium entry
edox
ypoxia
OS
STIM  and  ORAI  are  exposed  to oxidative  modiﬁcations  in  the ER,  the  cytosol,  and  at the  cell  surface,  and
redox-mediated  alterations  in  STIM/ORAI  coupling  might  contribute  to autoimmune  disorders  and  cancer
progression.  This  review  discusses  the  redox  reactivity  of  cysteine  residues  in  STIM  and  ORAI  isoforms,
focusing  on  the oxidative  modiﬁcations  of STIM  and  ORAI  proteins  by  which  STIM-ORAI  signaling  can  be
modulated.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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/).1. Introduction
All living organisms require calcium (Ca2+) which must be taken
up from the environment. In higher organisms, such as humans,
Ca2+ is a major component of the mineral phase of bone and
teeth and the plasma levels of Ca2+ are kept constant within nar-
row limits. At the cellular level, the cytosolic Ca2+ concentrations
are kept low, as calcium is central to a ubiquitous intracellular
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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essenger system that controls vital functions such as cell differ-
ntiation and proliferation, muscle contraction, hormone secretion
nd neurotransmitter release. Intracellular Ca2+ is a uniquely
ersatile signaling molecule because just about any Ca2+ spa-
iotemporal pattern can be generated by the coordinated action
f channels, pumps and exchangers, regulating Ca2+ ﬂuxes at the
lasma membrane (PM) and across intracellular organelles. Ca2+-
torage organelles include the endoplasmic reticulum (ER) and
ts sarcoplasmic reticulum (SR) equivalent in muscle cells, acidic
rganelles such as lysosomes and mitochondria which can pas-
ively take up Ca2+ by a regulated uniporter system [1,2]. Active
a2+ extrusion by plasma membrane Ca2+ ATPases (PMCA) and
equestration by SR/ER Ca2+ ATPases (SERCA) maintain the free
ytosolic Ca2+ concentration at nanomolar levels. The large gra-
ient generated by the pumps enables transient elevations in the
ocal Ca2+ concentration via controlled opening of Ca2+ release and
nﬂux channels, while Ca2+ binding proteins prevent the rapid dif-
usion of Ca2+ ions within the cytosol and favour their accumulation
nto Ca2+ stores. The Ca2+ depletion of the ER, in turn, activates Ca2+
ntry channels at the PM to sustain the reﬁlling of stores and the
aintenance of long-lasting Ca2+ signaling processes. This store-
perated Ca2+ entry (SOCE) process is particularly important for the
aintenance of long-lasting Ca2+ signals that drive transcriptional
esponse in immune cells.
The two major families of proteins that mediate the SOCE pro-
ess, STIM and ORAI, were discovered nearly 20 years after Putney
ormulated the concept that the content of Ca2+ stores controls the
pening of plasma membrane channels [3]. This concept stems
rom early observations that Ca2+ entry persists following ago-
ist or second messenger withdrawal and gained strong support
hrough the electrophysiological characterization of a Ca2+ release
ctivated Ca2+ current (CRAC) in mast cells and T cells [4]. This
rototypical current has a characteristic inward rectiﬁcation, an
xtreme selectivity for Ca2+, and a very small unitary conductance.
lthough in 2001, Yue et al. proposed that the calcium channel
RPV6 (also known as CaT1) assumes this role [5], genome-wide
NAi screens in Drosophila and human cell lines in 2005 and
006 (deploying NFAT translocation reporter assays among other
pproaches) revealed STIM1 and ORAI1 as the essential compo-
ents for Ca2+ entry and CRAC [6–9]. There are two  STIM isoforms
STIM1 and STIM2) and three ORAI isoforms (ORAI1, ORAI2, ORAI3)
n humans, and genetic linkage analysis pinpointed a mutation in
RAI1 (R91W) in a patient suffering from severe combined immun-
deﬁciency (SCID) associated with impaired SOCE in his T cells [10].
 cells from the SCID patient homozygous for the ORAI1-R91W
utation completely lacked CRAC currents that were restored by
he expression of wild-type (wt) ORAI1, ﬁrmly linking the defect
n CRAC channel function to ORAI1. Subsequent genetic studies
evealed the full spectrum of diseases associated with loss or gain of
unctions in STIM or ORAI, a phenotype now termed “CRAC chan-
elopathy”. Patients deﬁcient in STIM1 or ORAI1 function suffer
rom SCID-like immunodeﬁciency associated with recurrent and
hronic bacterial, viral, and fungal infections, and from blood, mus-
le and skin disorders that can comprise autoimmune hemolytic
nemia and thrombocytopenia, muscular hypotonia and atrophy
nd ectodermal dysplasia with hypocalciﬁed dental enamel and
nhidrosis. Gain-of-function mutations in STIM1 and ORAI1 have
een associated with bleeding disorders and tubular aggregate
yopathy (TAM), a skeletal muscle disorder causing muscular pain,
eakness and cramping with exercise.
STIM1 and its paralog STIM2 are single-pass ER Ca2+ sensing pro-
eins that act as intracellular ligands to control the gating of ORAI
hannels (Fig. 1). Their N-terminus extending into the ER lumen
ontains EF-hand calcium sensing domains while the C-terminal
ytosolic tail contains self-associating coiled-coiled motifs, a chan-
el activating domain (CAD, also known as STIM-ORAI activatingm 60 (2016) 142–152 143
region, SOAR) and a polybasic lysine(K)-rich C-terminal domain
that binds phosphoinositides [11–18]. A decrease in the free Ca2+
concentration within the ER lumen promotes an inside-out confor-
mational change that extends STIM1 cytosolic tail and promotes its
oligomerization as well as the exposure of the CAD/SOAR and the
lysine-rich tail. The resulting increased afﬁnity of STIM1 for lipids
promotes its accumulation within cortical ER structures, located
near phosphoinositide-rich domains of the PM or of organelles,
while the exposure of the SOAR allows STIM1 to trap ORAI1 chan-
nels via interactions with their C-terminal cytosolic domain. This
is followed by the gating of the trapped channel complex via
productive interactions of STIM1 with the N-terminal region of
ORAI1 [11,19,20], reviewed in Ref. [21]. As a result of these traf-
ﬁcking events and the conformational changes, both STIM1 and
ORAI1 accumulate within membrane clusters visible in the TIRF
microscope as ﬂuorescent “puncta”. Store depletion as well as
STIM1-enforced expression induces the extension of junctional ER
structures which can be visualized in the electron microscope as
extended thin sheets of cortical ER [22–25]. The STIM-ORAI cou-
pling process occurs at membrane contacts sites between the ER
and the target membranes. This structural arrangement, sustain-
ing lipid transfer between membranes, is conserved from yeast
to human. SOCE thus shares molecular and cellular components
that are essential for lipid homeostasis and proper assembly of the
STIM1 and ORAI complex. Activation of this complex requires a
range of associated proteins including CRACR2A, SARAF, STIMATE,
junctate, POST, and septins (reviewed in Ref. [26]). In addition
certain TRP channels located at the plasma membrane can also con-
tribute to SOCE [27–30]. The regulation of SOCE by the associated
proteins, by phosphorylation, and by Ca2+ itself, has been exten-
sively reviewed in Refs. [31,32]. In this present review, we focus on
recent studies reporting that the SOCE process can be modulated
by changes in the redox status of STIM and ORAI proteins, the core
components of the SOCE machinery. The sequential steps linking
store depletion to the activation of CRAC channels are summarized
below [26] (Fig. 1).
2. Redox regulation of STIM1
Human STIM1 contains ﬁve highly conserved cysteine residues
(Fig. 2A), one in the signal peptide, two just upstream of the canon-
ical EF-hand motif in the N-terminal luminal domain, one in the
transmembrane domain and another one in the conserved cytoso-
lic C-terminal STIM-ORAI activating region (SOAR). Two studies
have implicated the ER luminal cysteines (Cys-49 and Cys-56) in
the redox regulation of STIM1 [45,46].
2.1. Effect of oxidant challenges on STIM1-mediated SOCE
Hawkins et al. demonstrated that exposure of COS7 cells to
H2O2 or buthionine sulfoximine (BSO) redistributes exogenous
STIM1 from the perinuclear ER to PM puncta, indicating that oxida-
tive stress promotes oligomerization of STIM1 and activation of
SOCE [45]. A similar oxidant insult caused store-independent Ca2+
entry in mouse embryonic ﬁbroblasts (MEFs) but was  ineffective in
MEFs lacking STIM1, establishing STIM1 as an important oxidative
stress sensor [45]. In agreement with this, STIM1 knockout DT40
chicken B-lymphocytes were resistant toward oxidative stress-
induced SOCE, triggered by BSO or H2O2, and regained oxidant
sensitivity upon re-expression of STIM1 [45].
2.2. Redox reactivity of STIM1 luminal cysteinesH2O2 targets the reactive thiol groups of cysteines in proteins
and forms sulfenic acid (R-SOH), which undergoes nucleophilic
attack by another thiol (RSH), resulting in disulﬁde bond (RSSR)
144 R. Bhardwaj et al. / Cell Calcium 60 (2016) 142–152
Fig. 1. Schematic step-wise representation of SOCE pathway.
1)  At resting ER Ca2+ levels both STIM1 and ORAI1 form homodimers [33–37] and have diffused localization in the ER membrane and the PM,  respectively [10,25]. STIM1
forms  a dimer via intermolecular interactions involving cytosolic coiled-coil domains, as described in the text (also see Fig. 2).
2)  The agonist-induced stimulation of G-protein coupled receptors (GPCRs) or tyrosine kinase receptors (RTKs) activates phospholipase C or phospholipase C2 (PLC),
respectively resulting in hydrolysis of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] on the inner leaﬂet of PM and release of Inositol 1,4,5-trisphosphate (IP3).
3)  IP3 diffuses into the cytosol and binds to the IP3 receptor (IP3R) on the ER membrane causing release of ER Ca2+ from the IP3R.
4a)  STIM1 or STIM2, upon signiﬁcant or minor drop in ER Ca2+ concentration, respectively, lose Ca2+ bound to their EF-hand domains. Ca2+-dissociation activates the STIM
dimer by aggregation and interaction of EF-SAM domains in the ER lumen.
4b) Aggregation and interaction of EF-SAM induces an extended conformation of the cytoplasmic coiled-coil domains, leading to exposure of SOAR and the K-rich domain
(also  see Fig. 2).
5a) Activated STIM1 dimer further oligomerizes via coiled-coils and translocates to ER-PM contact sites.
5b) Oligomerized STIM1 binds PI(4,5)P2 at the inner leaﬂet of the PM avidly via their K-rich domains leading to extension and stabilization of ER-PM contact sites.
6)  Activated STIM1 oligomers and ORAI1 accumulate at ER-PM junctions.
7) The exposed SOAR domains of activated STIM1 oligomers activate the ORAI1 channel, leading to inﬂux of extracellular Ca2+ into the cytosol. Each exposed SOAR dimer
interacts with and activates one ORAI1 protein [38]. While the Drosophila structure reports a hexameric ORAI1 channel [39], human ORAI1 in its active state is suggested to
be  tetrameric [36,37]. Eight STIM1 molecules forming an active complex with one tetrameric ORAI1 channel are shown as per current stoichiometric model of STIM1-ORAI1
interaction [26,38].
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26] and others.
ormation. The direct redox reactivity of the ER-luminal cysteines
n STIM1 was investigated by exposing the recombinant human
TIM1 N-terminal fragment to 100 M H2O2 for 30 min. This treat-
ent failed to alter the protein mobility on non-reducing SDS-PAGE
evoid of DTT or any other reducing agent [45]. Thus, the authors
oncluded that oxidant stress does not facilitate the formation of
uminal disulﬁde bonds in STIM1. However the presence of a pre-
ormed disulﬁde bridge in STIM1 was not assessed since the protein
as not exposed to reducing conditions and the presence of cross-
inked cysteines might account for the failure of H2O2 to trigger
urther modiﬁcations.
Under oxidative stress conditions, reactive thiol groups of
roteins can undergo S-glutathionylation, a reversible reaction
etween cysteine residues of a protein and glutathione (GSH) that
lays important regulatory roles in redox signaling and oxida-
ive stress responses [47]. This was explored by Hawkins et al.
ho treated full length recombinant human STIM1 with 100 M
2O2 in presence of 10 mM GSH in a cell-free system and detected
 strong S-glutathionylation of STIM1 by Western blotting [45].
-glutathionylation was associated with the formation of higher
rder oligomers of STIM1, as indicated by a dramatic shift in the
olecular mass upon H2O2 treatment that exceeded by far the
ffect expected through addition of reduced GSH (the molecular
ass of which is only 0.307 kDa). Furthermore, upon DTT addition,
he recombinant human STIM1 ran at its calculated monomerice ER-PM contacts [40]. Figure was redrawn, using information from Soboloff et al.
molecular weight, regardless of the presence of H2O2, indicating
that the S-glutathionylation-mediated effect on STIM1 mobility is
reversible [45]. Importantly, the authors further showed that the S-
glutathionylation of puriﬁed recombinant human STIM1 decreases
its Ca2+-binding afﬁnity by at least 5-fold [45]. These ﬁndings indi-
cate that S-glutathionylation of STIM1 mimics the effects of luminal
Ca2+ depletion and promotes the oligomerization of STIM1.
Subsequently, Hawkins et al. showed that Cys-56 in STIM1 is the
target of S-glutathionylation under H2O2-induced oxidative stress,
based on studies using lysates from COS7 cells expressing wt STIM1
or the C56A, C49A and C49/56A mutants [45]. The decreased afﬁn-
ity of S-glutathionylated STIM1 for Ca2+-binding triggers STIM1
oligomerization, thereby facilitating constitutive Ca2+ entry and
increasing basal cytosolic Ca2+ levels [45]. Somewhat unexpect-
edly, alanine substitution at Cys56 alone or at Cys49 and Cys56
led to constitutive Ca2+ entry when the mutated STIM1 proteins
were expressed in STIM1−/− DT40 cells, possibly due to allosteric
modulation of the proximal EF-hand domain, thereby impairing
Ca2+-binding [45]. Consistent with this hypothesis, when HEK293T
cells were co-transfected with ORAI1 and either C56A mutant or
the C49/56A double mutant STIM1, a substantial redistribution of
STIM1 towards the PM and colocalization with ORAI1 was  observed.
Furthermore, coexpression of ORAI1 and STIM1 C49/56A in HEK293
resulted in a constitutive CRAC current [45].
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In a separate study, Prins et al. reported that YFP-STIM1 pro-
ein derived from MEFs migrated slightly faster on PAGE under
on-reducing conditions than under reducing conditions, suggest-
ng the presence of an intramolecular disulﬁde bond in STIM1 [46].
he redox-dependent migratory shift was absent in the YFP-STIM1-
49/56A double cysteine mutant, indicating a possible involvement
f these residues in creating an intramolecular disulﬁde bridge
46]. This observation is at odds with the ﬁndings of Hawkins
t al. who failed to provide evidence for disulﬁde bridge forma-
ion between C49 and C56. The double STIM1 cysteine mutant had
ltered mobility when expressed in MEFs lacking the ER-resident
xidoreductase ERp57 [46], suggesting that ERp57 is dispensable
or the formation of the luminal disulﬁde bridge in STIM1. Bio-
hemical and functional evidence for an association between Erp57
nd STIM1 was obtained: Erp57 was shown to interact with the
R luminal N-terminal domain of STIM1 by surface plasmon reso-
ance, and overexpression of YFP-STIM1 and ERp57-CFP generated
 robust FRET signal in resting and store-depleted Stim1−/− MEFs,
ndicating that these two proteins interact [46]. Coexpression of
FP-STIM1 C49/56A and ERp57-CFP in Stim1−/− or ERp57−/− MEFs
esulted in a 33% or 28% lower FRET signal, respectively compared
o wt STIM1 indicating that the luminal C49 and C56 contribute
o the binding of STIM1 to ERp57 [46]. Finally, deletion of ERp57
n MEFs caused partial pre-clustering of STIM1 and potentiated
OCE whereas overexpression of ERp57 had the opposite effect [46].
ig. 2. Schematic outline of the domain architecture of human STIM1 and STIM2 isofor
uman STIM1 and STIM1L [41] isoforms, comprising 685 and 791 amino acid residues, r
omprising 833 residues are shown. Shown are the signal sequence (SS), the canonical E
F-hand domain (hEF), the sterile alpha motif (SAM), the transmembrane domain (TMD
26] STIM-ORAI activating region (SOAR), four -helices of SOAR (S1-4), the inactivatio
egion (S/P), the proline/histidine-rich region (P/H), the microtubule plus end-tracking pr
n  STIM2 (Ser/Thr-x-Ile-Pro), the lysine (K)-rich domains with their amino acid sequence
lycosylation sites are shown as hexagons. Arginine retention signals (RXR) are depicted
cid  insertion in the SOAR in STIM2 inhibitory splice variant [43,44] is shown on both (B)m 60 (2016) 142–152 145
These data indicate that ERp57 binding to STIM1 has inhibitory
effect on SOCE by hindering the recruitment of STIM1 to puncta.
However, robust evidence for disulﬁde bridge formation between
C49 and C56 of STIM1 and its involvement in SOCE regulation still
remains to be provided.
Although the two  studies support the notion that STIM1 is reg-
ulated by redox state, highlighting the importance of the luminal
cysteine residues in this regulation, they diverge on the functional
consequences. When expressed in Stim1−/− MEFs, the YFP-STIM1-
C49/56A double mutant showed ER-like reticular localization and
failed to form puncta even in store-depleted conditions [46]. In con-
trast, the same mutant was  constitutively recruited to puncta when
expressed in HEK-293 cells [45]. In keeping with this diverging
localization, the YFP-STIM1 C49/56A double mutant did not medi-
ate SOCE when co-expressed with ORAI1-dsRed in Stim1−/− MEFs
[46] but was  constitutively active when co-expressed with ORAI1 in
HEK-293 cells [45]. The simplest explanation for this discrepancy is
that endogenously expressed STIM1 of HEK-293 cells participate in
plasma membrane recruitment of the STIM1 mutants. Other pos-
sible explanations might be related to different amounts of ROS
and antioxidants and/or the presence of ancillary proteins in the
two different cell lines used for STIM1 expression. Nevertheless, in
spite of all the discrepancies, both studies conﬁrm that Cys49 and
Cys56 are both critical for SOCE regulation.
ms drawn to scale with conserved cysteine residues shown as yellow circles. (A)
espectively (B) STIM2, comprising 746 amino acids and (C) STIM2 preprotein [42],
F-hand domain (cEF) with amino acid sequence of Ca2+-binding loop, the hidden
), the coiled-coil domains 1–3 (CC), the three predicted -helices of CC1 (C1-3)
n domain (ID), the actin-binding domain (ABD) in STIM1L, the serine/proline-rich
otein (EB1)-binding motif—TRIP motif in STIM1 and the analogous SGIP/SSIP motifs
s (all with residue numbers) and the orientations of N- and C-termini. Asn-linked
 as blue circles with residue numbers indicated on STIM1 and STIM2. The 8 amino
 STIM2 and (C) STIM2 preprotein.
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The most parsimonious explanation of these diverging obser-
ations is that a disulﬁde bond forms between C49 and C56 in
he oxidative environment of the ER, stabilizing the STIM1 rest-
ng conformation by maintaining its luminal EF-hand domains in
 high-afﬁnity state. Disruption of this bond would destabilize
TIM1 but does not promote the extension of its cytosolic domain
t resting luminal Ca2+, unless it oligomerizes with endogenous
TIM1 (HEK cells), while S-glutathionylation at these sites poises
TIM1 for activation by decreasing luminal calcium sensing and
romoting the extension of its cytosolic domain and thus the for-
ation of active STIM1 oligomers. Further experimental work will
e required to clarify the precise role of these luminal cysteine
esidues in STIM1 function.
.3. Cytosolic and TMD-cysteines in regulation of STIM1 function
Formation of disulﬁde bridges has been thought to be limited to
he oxidative milieu of the ER, as the reducing environment of the
ytosol was considered to prevent the creation of disulﬁde bonds
48]. However, in recent years, it has been recognized that thi-
ls in cytosolic proteins may  actually form disulﬁde bridges under
xidative stress conditions, due to saturation of the major cytoso-
ic thiol-reducing systems, rendering cytosolic cysteines prone to
xidation [49]. Under such conditions, for example, mitochondrial
OS were shown to cause the redox-modulation of three proxi-
al  cysteine residues present in the cytosolic tail of the human
ardiac L-type Ca2+ channel, leading to inhibition of this channel
50]. STIM1 possess a cytosolic cysteine at position Cys-437 that
ould mediate reversible intermolecular disulﬁde bridge formation
etween STIM1 molecules during oligomerization but the redox
eactivity of this residue has not yet been studied.
Cys-437 of STIM1 is the last C-terminal residue of the S4 helix
Fig. 2A) in the highly conserved CAD/SOAR [51]. Several investiga-
ors performed mutagenesis at this site. Park et al. demonstrated
hat the mCherry-STIM1 C437G mutant trafﬁcked normally to PM
uncta upon store-depletion and co-localized with eGFP-ORAI1,
ut was ineffective at inducing SOCE in HEK293 cells [11]. The initial
ate of SOCE was 4-fold lower for the C437G mutant compared to wt
TIM1, while the fraction of STIM1 or ORAI1 in puncta under rest-
ng and store-depleted conditions were similar for both mutant and
t STIM1 [11]. These data indicate that Cys-437 is not needed for
TIM/ORAI clustering but plays a direct or indirect role in channel
pening.
The involvement of Cys-437 of SOAR in SOCE regulation was
urther addressed in two biochemical studies. Yang et al. crystal-
ized SOAR from human STIM1 and mutated the Cys-437 residue to
hr to improve the crystallization process. They conﬁrmed that this
ubstitution, along with the L347M and V419A mutations, did not
ffect the PM targeting of SOAR-eGFP and STIM1-eGFP before and
fter store depletion. Both the WT  and mutant SOAR coimmuno-
recipitated with the exogenously expressed ORAI1 channel and
ediated SOCE when expressed in HeLa cells [51]. Analytical ultra-
entrifugation revealed that human wt SOAR is partially tetrameric
n solution, whereas SOAR bearing the C437T, L347M and V419A
utations exclusively forms dimers [51], hinting towards a possi-
le role of this cysteine residue in regulating the oligomeric state of
TIM1. In another study, Zhou et al. employed a lanthanide-based
esonance energy transfer approach to investigate the conforma-
ional changes in STIM1 C-terminus during activation of STIM1
52]. For this, a cysteine was added to the C-terminus of the puri-
ed recombinant full-length C-terminal fragment (res. 233–685)
f mouse STIM1 (STIM1CT) for labelling with an acceptor ﬂuo-
ophore, and C437 was substituted by serine. They found that
TIM1CT is in a locked conformation with its C-terminal K-rich
omain in close proximity to the N-terminus of CC1. Further, their
ata suggests that CC1 dimerize during activation of STIM1 whichm 60 (2016) 142–152
releases SOAR from association with monomeric CC1, thereby
exposing SOAR and the K-rich domain to interact with ORAI1 and
PM lipids, respectively. Size exclusion chromatography revealed
that the STIM C-terminus with this cysteine mutation still formed
dimers, excluding its role in dimer formation, and the similar CD
spectra of mutant and wt  STIM1 C-termini showed that this residue
does not deﬁne the conformational state of STIM1 [52].
Together, these ﬁndings indicate that Cys-437 of STIM1 might
not be critical for producing conformational changes in STIM1.
However, single point mutations of this residue appear to adversely
interfere with CAD/SOAR-mediated channel gating. Thus, whether
the cysteine 437 is still involved in intermolecular disulﬁde bridge
formation and/or whether it contributes toward the redox regula-
tion of STIM1 remain open questions.
Fuchs et al. reported two  immunodeﬁciency syndrome patients
with a homozygous mutation of Arg-429 located at the distal end
of CC3 of STIM1 to cysteine. This mutation completely abolished
SOCE in T-cells of these patients [53]. Fibroblasts from a patient car-
rying the homozygous R429C mutation were incapable to undergo
SOCE, while transduction with wt  STIM1 rescued SOCE [54]. It was
shown that R429C destabilizes the structure of this CC3 coiled-coil
and impairs intra- and intermolecular STIM1 protein interactions.
This mutation also leads to a conformational change causing exten-
sion of STIM1 C-terminus exposing the K-rich domain thereby
promoting constitutive translocation of STIM1 to ER-PM contact
sites [54]. R429C also impaired the oligomerization of STIM1 C-
terminus and binding of STIM1 to ORAI1, thereby abolishing SOCE.
However, STIM1-R429E or R429L also abolished SOCE in HEK293
cells (coexpressed with ORAI1), as did STIM1-R429C, suggesting
that the effect does not depend on the substitution to cysteine [54].
Nevertheless, it is of interest to consider whether genetic mutations
leading to cysteine substitutions in SOCE components are evolu-
tionary favoured to enhance the sensitivity toward oxidative stress
as an additional regulatory factor.
Does ER-transmembrane cysteine 227 of STIM1 regulate STIM1
activity? The redox reactivity of C227 present in the transmem-
brane domain (TMD) of STIM1 has not been investigated. Ma  et al.
showed that a mutation of this residue to tryptophan reorients
the TM helices and causes elongation of the cytoplasmic domain
of STIM1, leading to constitutive STIM1 activity and calcium entry
[55]. These data suggest that the TMDs of the STIM1 dimer in the
resting state are associated with each other in the membrane and
that a local rearrangement within the TMDs initiate conformational
changes in the C-terminal domain of STIM1, without alteration of
the oligomeric state, to activate STIM1 and subsequently expose
SOAR to gate ORAI channels.
2.4. STIM1 and Hypoxia/ROS
Hypoxia, a condition marked by inadequate supply of oxygen to
cells, increases reactive oxygen species (ROS) generation through
mitochondrial complex III, causing nuclear accumulation of the
transcription factor subunit HIF-1,  the key cellular oxygen sensor
[56,57]. HIF-1 regulates the expression of numerous target genes
involved in maintaining oxygen homeostasis and thereby increases
vascularization in hypoxic areas found at sites of focal ischemia and
within tumors [57–59]. The hepatocarcinoma cell lines, HepG2 and
Huh-7 exhibited, upon hypoxic treatment (cultured in 1% O2 for
24 h), enhanced expression levels of HIF-1  and STIM1 but not of
STIM2 [60]. In agreement with this, Li et al. reported that hypoxic
conditions enhanced SOCE and ICRAC in HepG2 cells. Also, downreg-
ulation or pharmacological inhibition of HIF-1 in hypoxic HepG2
cells led to decreased expression levels of STIM1 and concomitantly
reduced SOCE. In addition to the drop in STIM1 expression, phar-
macological inhibition of HIF-1 also suppressed xenograft hepatic
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umorigenesis [60]. Altogether, these ﬁndings reveal a role of STIM1
n hypoxia and hypoxia-driven tumorigenesis.
Several studies showed that induction of hypoxia/oxidative
tress with either the O2 scavenger sodium dithionite (Na-Dit), low
1.5%) O2-containing medium or tert-butyl hydroperoxide (tBHP)
romotes accumulation of endogenous or overexpressed STIM1
t ER-PM junctions in various cell lines [61–63]. In two back-
o-back publications, Gusarova et. al and Mungai et al. reported
hat hypoxia-stimulated ROS production (1.5% O2) and oxidant sig-
aling cause store-depletion and trigger CRAC channel activation,
s assessed by pharmacological and RNA-silencing approaches in
uman A549 adenocarcinomic alveolar basal epithelial cells and
43B osteosarcoma cells, respectively [61,63]. Another group, how-
ver, observed that hypoxic treatment (1 mM Na-Dit) of HEK293
r human airway smooth muscle cells (hASMC) inhibited Tg-
nduced SOCE and ICRAC, but this inhibition was  attributed to the
ytosolic acidiﬁcation evoked by Na-Dit, which prevented func-
ional coupling between STIM1-SOAR and the C-terminal tail of
RAI1 despite clustering of STIM1 at ER-PM junctions [62]. The
uthors further showed by FRET analysis that Na-Dit addition after
tore-depletion impaired the STIM2-ORAI1 interaction and that
ytoplasmic alkalization with ammonium chloride reversed the
nhibition of STIM1-ORAI1 interaction and ICRAC [62]. Consistent
ith these ﬁndings, others also reported internal and external
cidosis-induced inhibition of SOCE and ICRAC, and several residues
ere identiﬁed that confer pH sensitivity to ORAI1 [64–67].
Different mechanisms were proposed to account for the
ypoxia-mediated store-depletion. Mancarella et al. demonstrated
hat hypoxia leads to a reduction in ATP levels which decreases
ERCA-mediated Ca2+ pumping in the ER, resulting in Ca2+-store
epletion [62]. In contrast, Gusarova et al. and Mungai et al.
eported no changes in ATP levels upon hypoxia induction with
.5% O2 [61,63]. A direct role of ROS in STIM1 activation was
hown by trapping ROS using the oxidative species scavenger
UK-134 [61]. Scavenging ROS prevented the clustering of endoge-
ous STIM1 in hypoxia-treated ATII alveolar epithelial cells. Also,
ypoxia-triggered intracellular Ca2+ release and SOCE were absent
n A549 adenocarcinomic human alveolar basal epithelial cells
ither devoid of mitochondria or of a component of mitochon-
rial complex III which is crucial for ROS generation. Further
esearch is required to clarify the mechanism of the reported
ffects of hypoxia/ROS on CRAC channel activation or inhibi-
ion. Gusarova et al. and Mungai et al. did not measure pH in
heir experiments and given that acidosis/alkalosis leads to inhi-
ition/potentiation of SOCE [64–67], pH differences could explain
he discrepancies reported by Mancarella et al. [61–63]. Alterna-
ively, a distinct expression ratio of STIM isoforms (STIM1L, STIM2,
nhibitory isoform of STIM2) [41,43,44] might account for the dif-
erent sensitivities toward hypoxia/ROS of the cell lines used. It will
lso be of interest to determine whether ROS generated by mito-
hondria have a different effect on STIM1 function than externally
dded ROS.
.5. Redox-regulation of the actin-binding isoform of STIM1
STIM1L is a splice variant of STIM1 with an additional actin-
inding domain downstream of SOAR. This enables STIM1L to
ind cortical actin in muscle cells in order to form permanent
lusters that colocalize with ORAI1, even under resting ER Ca2+
evels [41]. This renders STIM1L able to rapidly activate ORAI1
pon store-depletion without undergoing redistribution of the pre-
ormed clusters [41]. This prerecruitment of STIM1L to cortical actin
s required for very rapid activation of SOCE during repetitive mus-
le contraction. STIM1L encompasses an additional cysteine residue
n its actin-binding domain (Fig. 2A). Interestingly, STIM1L expres-
ion is detected in all skeletal muscles and many different tissuesm 60 (2016) 142–152 147
such as brain, lungs, liver, spleen, and heart but not in the kidney,
suggesting that the constitutive pre-clustering of STIM1L-ORAI1
under resting conditions may  be a common feature of the SOCE
pathway in different cell types. However STIM1L did not form con-
stitutive membrane clusters when expressed in ﬁbroblasts [68]
indicating that accessory proteins are likely required to recruit
STIM1L to cortical structures. Whether hypoxia/ROS regulate the
activity of this STIM1 isoform is not known but the presence of an
additional cysteine residue within its actin-binding domain sug-
gests that the pre-recruitment of STIM1L to cortical actin might be
regulated in a redox-dependent manner.
During acute hypoxia, STIM1 associates with both ORAI1 and
TRPC1 to mediate SOCE in mouse PASMCs [69]. The association
of STIM1L with TRPC1 has not yet been tested, but STIM1L binds
to ORAI1 with a 4-fold higher afﬁnity than STIM1 and associates
with TRPC3 and TRPC6, leading to stronger inhibition of receptor-
operated Ca2+ entry via these TRPC channels [70]. STIM1 was  also
shown to interact with and inhibits voltage-operated calcium chan-
nel CaV1.2 [71], but whether STIM1L similarly regulates CaV1.2
has not yet been demonstrated. The speciﬁc interactions involv-
ing STIM1 or STIM1L with STIM-regulated PM calcium channels
other than ORAI (TRPC or L-type calcium channels) might lead to
different redox sensitivities in different cell-types, depending on
their expression levels. The redox regulation of these channels has
recently been reviewed [72,73].
In mouse models of muscular dystrophy, increased SOCE was
associated with the upregulation of ORAI1, STIM1, and STIM1L
[74]. The ratios of STIM1L to STIM1S were similar in wt and
dystrophic mdx  muscle and PMCA expression was increased, bal-
ancing the inhibitory effect of STIM1 on PMCA and preserving the
Ca2+ extrusion capacity of muscle ﬁbers [75]. The causal role of
SOCE in the pathology of dystrophic muscle was directly tested
in a mouse model of muscle-speciﬁc STIM1 overexpression [76].
Enhanced muscle-speciﬁc expression of STIM1 was associated with
increased Ca2+ inﬂux and with typical histological and biochemi-
cal features of muscular dystrophy, including myoﬁber necrosis,
swollen mitochondria, increased inﬂammation, interstitial ﬁbrosis,
and elevated creatine kinase levels [76]. Most of these pathological
features were reverted by expressing a dominant-negative ORAI1
mutant, which also signiﬁcantly reduced the severity of muscular
dystrophy in two  mouse models of the disease [76]. This ﬁrmly
links increased STIM1-ORAI1 activity to muscular dystrophy, but
whether an altered redox regulation of STIM1, STIM1L, and/or ORAI
proteins participate in the increased SOCE of dystrophic myoﬁbers
is not known.
3. Redox regulation of STIM2
3.1. Lower Ca2+ activation threshold of STIM2 compared to STIM1
The afﬁnity of the STIM2 EF-hand domain for Ca2+ is about
400 M whereas that of STIM1 is 200 M [77]. This difference in
the EF-hand Ca2+-binding afﬁnity renders STIM2 active at basal
ER Ca2+ concentrations (∼400 M)  and sensitive to small reduc-
tions in ER Ca2+, whereas STIM1 needs a higher drop in ER Ca2+
concentration for activation [78]. Thus, STIM2 may  function as a
feedback regulator that stabilizes basal cytosolic and ER Ca2+ levels.
STIM2, in addition to lower Ca2+ afﬁnity of the EF-hand, has higher
afﬁnity of its C-terminal K-rich domain for PI(4,5)P2. The increased
lipid-binding avidity enables STIM2 to cluster at ER-PM junctions
in response to minimal depletion of ER Ca2+ stores [12,79].3.2. Differential expression of STIM isoforms
While most tissues express higher levels of STIM1 than STIM2
[80–82], the levels of STIM2 protein in brain are higher than those of
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TIM1 [83]. STIM2 is the predominant STIM isoform in mouse pri-
ary hippocampal and cortical neurons and is essential to induce
OCE [83–86]. STIM2, like STIM1 can also activate all the three
RAI isoforms upon store-depletion [87]. However, different STIM
soforms can contribute to Ca2+ entry in different cell types. For
xample, Bandyopadhyay et al. demonstrated that STIM2 regulates
OCE by coupling to ORAI2 in mouse dendritic cells [88].
.3. Role of STIM2 in ER-PM coupling and constitutive calcium
ntry
The expression of a chimeric ER membrane protein, i.e. Kir6.2,
used to the C-terminus of STIM2, led to constitutive ER-PM con-
act formation, whereas fusion of Kir6.2 with the C-terminus of
TIM1 remained reticular, indicating that STIM2 leads to con-
titutive coupling of ER and PM [79]. STIM2 also has a higher
ipid-binding afﬁnity than STIM1 in PI(4,5)P2-containing liposome-
inding assays [12]. The higher afﬁnity of the C-terminal K-rich
omain of STIM2 for PI(4,5)P2 at the PM thus favors the recruit-
ent of STIM2-containing ER to the PM,  even in resting conditions
12,79]. Overexpression of STIM2, but not STIM1 had been reported
o trigger constitutive Ca2+ entry [89] and cortical neurons co-
ransfected with YFP-STIM2 and ORAI1 had much higher resting
a2+ levels than neurons expressing YFP-STIM1 and ORAI1 [84].
ven though STIM2 is a poor activator of ORAI1 [90], altogether
hese ﬁndings suggest that the higher lipid-binding afﬁnity of
TIM2 leads to constitutive recruitment of STIM2 in ER-PM con-
acts, resulting in constitutive Ca2+ entry by activation of PM Ca2+
hannels. Recent ﬁndings from Ong et al. suggest that, under
ild depletion of ER Ca2+ stores, STIM1 is corecruited to ER-PM
ontact sites with STIM2. In this recruitment of STIM1-STIM2 het-
rooligomers, the K-rich domain of STIM2 is indispensable [91].
herefore, in the light of the formation of mixed STIM1 and STIM2
omplexes, the function of STIM2 isoform and its redox-regulation
s of great interest.
.4. Redox-regulation of STIM2
The luminal cysteine residues present in STIM1 are also con-
erved in STIM2. Moreover, there is a higher number of conserved
ysteine residues present in the C-terminal domain of STIM2
ompared to STIM1 (eleven versus one) which may  indicate the
ossibility of redox-mediated STIM2 activation (Fig. 2B). While it
s established that (1) STIM1 forms homodimers at resting state
ia coiled-coil domains [33–36,92] and (2) unlocking of the STIM1
rotein exposes the K-rich domain during activation-driven con-
ormational changes [52], the resting assembly state of STIM2 and
he exposure state of its K-rich domain is unknown. Given the
igh degree of sequence homology between the STIM1 and STIM2
oiled-coil domains, it is likely that STIM2 also forms dimers at
esting state. Therefore, it is tempting to hypothesize that the
edox environment in the cytosol can regulate the intermolecular
eversible thiol bridge formation involving the cysteines present
n the cytosolic tail of STIM2, triggering the extension and activa-
ion of the STIM2 molecule, thus allowing it to increase the ER-PM
oupling.
Enhanced ER-PM contact formation may  stimulate STIM2-
ependent activation of Ca2+-channels which may  lead to chronic
a2+ overload and ﬁnally to necrosis and cell death by apoptosis
93]. Consistent with a redox-related modulation of STIM2 func-
ion, it had been reported that neuronal cells of Stim2−/− mice fail
o undergo apoptosis under oxidative stress conditions [83]. How-
ver, there is no direct evidence for redox-related control of STIM2
ctivity.
Upregulated protein levels of STIM2 were reported under
hronic hypoxic conditions in rat pulmonary arterial smoothm 60 (2016) 142–152
muscle cells (PASMCs) [94]. Also, increased levels of STIM2 pro-
tein but not STIM1 were found in PASMCs of idiopathic pulmonary
arterial hypertension patients [94]. It had been reported that STIM2
knockdown decreased SOCE in response to acute hypoxia in PASMC
but to a lesser extent when compared to STIM1 knockdown [95].
Altogether these data indicate a redox-regulated role of STIM2 in
mediating SOCE.
3.5. Reactivity of STIM2 cytosolic cysteines
Bhardwaj et al. showed that the oxidation of the last C-terminal
cysteine of STIM2 at position 725 (located just upstream of the
lipid-binding K-rich domain) led to the dimerization of the puriﬁed
recombinant eGFP-tagged polybasic domain of STIM2. This dimer
exhibited high afﬁnity binding to PI(4,5)P2-containing PM-like lipo-
somes in vitro [12]. Under reducing conditions this recombinant
protein, however, is a monomer and failed to bind PM lipids [12].
It remains to be determined whether, in vivo, oxidation of cys-725
in STIM2 (or by any other cytosolic cysteine residues) may  place
in close proximity the two  STIM2 monomeric units of the lipid-
binding domains and whether this dimerization is sufﬁcient for
ER-PM contact formation and activation of PM Ca2+ channels.
3.6. Redox regulation of other STIM2 isoforms
STIM2 preprotein (Fig. 2C) generated by inefﬁcient cleavage
of the signal peptide, is localized in the cytosol and has been
implicated in a store-independent mode of SOCE activation [42].
Whether this isoform, now having all the cysteines of STIM2
exposed to the redox environment of the cytosol, can be modi-
ﬁed upon variation of the intracellular redox conditions, thereby
modulating SOCE, would be the subject of additional investigations.
Recently a new STIM2 inhibitory isoform containing an eight-
residue insert in its SOAR (Fig. 2B) that disrupts its binding to
ORAI1 has been identiﬁed and studied [43,44]. We also noticed
that the STIM2 preprotein isoform [42] also exists as a variant
with this 8-residue insertion (NCBI accession number: AAI36450
or AAI71766). These inhibitory isoforms of STIM2 are interesting
modulatory players of SOCE and need to be investigated in the
context of redox regulation, as all the cysteines residues present
in STIM2 are also conserved in these isoforms. Moreover, the ﬁnd-
ing that the inhibitory isoform of STIM2 which is retained in the ER
can oligomerize with other STIM isoforms and can be recruited to
CRAC channels, thereby inhibiting the Ca2+ inﬂux, suggests that the
redox modulation of STIM isoforms can have either a potentiating
or an inhibiting effect on SOCE [44].
4. Redox regulation of ORAIs
The topology and domain architecture of the tetra-spanning PM
ORAI calcium channel subunits are presented in Fig. 3. The function
of ORAI proteins has been shown to be differentially regulated by
oxidative stress [96]. Three cysteine residues are present in ORAI1,
Cys-126 in the second TMD, Cys-143 in the cytosolic loop between
TMD 2 and TMD  3 and Cys-195 at the extracellular end of the third
TMD  (Fig. 3). C126 and C143 are conserved in all the three ORAI
isoforms whereas Cys-195 is missing in ORAI3 and is substituted
by a glycine (Fig. 3). ORAI3 has a 34 residue longer extracellular
loop between the third and fourth TMD  and this loop contains two
additional cysteine residues located ﬁve residues apart, which are
not present in ORAI1 or ORAI2.
Bogeski et al. studied the redox reactivity and sensitivity of
the ORAI isoforms in naive and effector T cells and in HEK293
cells coexpressing each ORAI isoform along with STIM1 [96]. They
reported that a pre-treatment with H2O2 before store depletion
inhibited the ORAI1- and ORAI2-mediated calcium inﬂux, whereas
R. Bhardwaj et al. / Cell Calcium 60 (2016) 142–152 149
Fig. 3. ORAI proteins share common topology. Cysteine residues in ORAI1 are indicated as yellow circles with residue numbers and sequence alignments of segments from
each  ORAI isoform spanning the corresponding cysteine residues. Cysteines in the alignments of ORAI isoforms are highlighted in bold and square boxes. The glycosylation
site  of ORAI1 (N223) is shown in blue circle with a hexagon. Putative STIM1-binding site at the N-terminus of ORAI1 (residues 73–85) [19] and the coiled-coil domain in
O re de
G n TM
t
m
a
o
c
s
r
i
t
s
G
1
c
[
c
[
i
i
a
a
v
i
c
q
c
[
e
a
o
t
ORAI1  at the C-terminus (residues 268–291) [9] spanning the STIM1-binding site a
ly-98  (gating hinge) on the TMD  1 of ORAI1 are indicated as yellow lines. Arg-91 o
he ORAI3-mediated calcium inﬂux remained resistant to H2O2-
ediated block. Lack of Cys-195 in ORAI3, which was  identiﬁed
s major redox sensor in ORAI1, was reported to be the cause
f this differential redox sensitivity of ORAI1 and ORAI3. Cal-
ium imaging and electrophysiological recordings revealed that
ubstitution of Cys-195 of ORAI1 to the non-oxidizable serine
esidue conferred partial resistance to H2O2-block, without chang-
ng the ion selectivity of the channel, whereas mutation of all
hree cysteines to serines completely abolished the redox sen-
itivity of ORAI1 [96]. Supporting this ﬁnding, a mutation of
ly-170 in ORAI3 to cysteine (at a homologous position to Cys-
95 of ORAI1, see Fig. 3) conferred redox-sensitivity to ORAI3,
onﬁrming that Cys-195 is a critical redox sensor in ORAI1
96].
Bogeski et al. also showed that the CRAC channels in effector TH
ells are less vulnerable toward H2O2 than those in naive TH cells
96]. Mild H2O2 treatment (10 M)  led to a 50% decrease in Ca2+
nﬂux upon store-depletion in naive T cells and a marginal decrease
n effector TH cells. Similarly, acute H2O2 treatment (500 M)
lmost completely inhibited the CRAC current in Jurkat T cells
nd had only a partial inhibitory effect in effector TH cells (87%
s. 40% inhibition of ICRAC [96]). The decreased redox sensitiv-
ty of effector TH cells compared to undifferentiated naive T cells
orrelated with upregulation of ORAI3 in TH cells as assessed by
RT-PCR. Moreover, silencing ORAI3 mRNA in human effector TH
ells rendered store-operated Ca2+ inﬂux more redox sensitive
96]. This showed that effector TH cells, by upregulating ORAI3
xpression and thus decreasing the ORAI1:ORAI3 ratio, undergo remarkable adaptation to protect the SOCE mechanism while
perating in the harsh oxidative environment during inﬂamma-
ion. Consistently, expressing STIM1 together with ORAI1 and
RAI3 at a ﬁve to one ratio in HEK293 led to 45% block of ICRACpicted as black thick lines. Glu-106 (selectivity ﬁlter), Val-102 (hydrophobic gate),
D1 of ORAI1 that is mutated to Trp in SCID patients [10] is indicated with red line.
by 1 mM H2O2, whereas expressing STIM1 and ORAI1 without
ORAI3 led to 80% block [96]. These ﬁndings demonstrate that
ORAI1 is redox-sensitive and mediates the H2O2 inhibition of ICRAC
and that upregulation of ORAI3 can tune this ICRAC inhibition by
generating redox-resistant ORAI3 homomers or by participating
in heteromeric complexes (ORAI1/ORAI3). In support for this, a
recent study using heteromeric concatenated channel subunits
(one ORAI3 and three ORAI1) showed that a single subunit of ORAI3
can confer redox resistance to ORAI1-ORAI3 heteromeric channels
[97]. The authors also showed that ORAI1 facilitates the recruitment
of ORAI3 to STIM1 clusters at ER-PM junctions in HEK293 cells and
also that ORAI1 in Jurkat T cells is required for escorting ORAI3 to
an immunological synapse mimic. Altogether these ﬁndings further
support the notion that ORAI3 might work together with ORAI1 in a
heteromeric complex to bring about resistance to oxidative stress.
Interestingly, active STIM/ORAI complexes formed after store-
depletion in T cells and in STIM1-ORAI1 overexpressing HEK293
cells were found to be resistant to H2O2-mediated inhibition of
calcium entry, ruling out a possible open channel block by H2O2
[96]. This suggests that ORAI1 undergoes a conformational change
when docked with STIM1 that alters the accessibility of the extra-
cellular Cys-195 to oxidants, thus imparting redox resistance to
ORAI1-mediated Ca2+ inﬂux after store-depletion. In such a sce-
nario, the STIM1L isoform, which is pre-coupled to ORAI1, could
maintain the channel in a redox-insensitive state. Further inves-
tigation is required to understand the molecular mechanism by
which H2O2 inhibits ORAI1 function and the impact of the redox
changes in channel state on the STIM-ORAI1 interaction.Altered ORAI1/ORAI3 expression ratios have been reported to
play a role in abnormal calcium signaling in prostate cancer [98,99].
Since prostate cancer cells are exposed to elevated levels of ROS
[100], it would be of great pathophysiological interest to study
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he mechanism of redox-modulation of ORAI1-ORAI3 heteromeric
hannels, functioning in calcium store-dependent manner or in
 store-independent manner regulated by stimuli such as arachi-
onic acid [101] or leukotriene C4 [102].
. Concluding remarks
STIM and ORAI proteins are the core components of the store-
perated Ca2+ entry process that sustain long-lasting Ca2+ signals
equired for the proliferation and differentiation of T lympho-
ytes and for the development of skeletal muscle cells. Loss
f function mutations in STIM and ORAI are associated with
evere immunodeﬁciency [10,103] and with muscular hypotonia
nd gain-of-function mutations with tubular aggregate myopathy
104–106] (reviewed in Ref. [107]). Reactive oxygen species mod-
late SOCE activity in immune cells and in STIM/ORAI expression
ystems but the molecular basis and functional signiﬁcance of this
edox regulation are unclear. The SOCE machinery is exposed to
ocal redox alterations occurring within the ER lumen and at the
lasma membrane, as STIM proteins sense a drop in the luminal ER
a2+ concentration and redistribute to the cell periphery to trap and
ate ORAI channels at ER-PM contact sites. Two cysteine residues in
TIM1 luminal domain (Cys-49 and Cys-56) have been implicated
n redox sensing within the lumen of the ER and a cysteine within
RAI1 extracellular loop (Cys-195) has been implicated in redox
ensing of extracellular hydrogen peroxide. Interactions with the
RAI3 isoform lacking Cys-195 renders ORAI1 redox resistant and
ight represent an adaptive mechanism to preserve SOCE function
n oxidative conditions. Whether interactions with STIM proteins
lso modulate the redox sensitivity of ORAI1 remains to be deter-
ined. Future research should explore the role of the additional
ytosolic cysteines present in the STIM2 isoform, which has distinct
a2+ sensing, lipid binding, and ORAI gating efﬁciencies, and in the
TIM1L isoform, which is pre-recruited to cortical actin structures.
ore work is also needed to clarify whether cytosolic cysteine
esidues within STIM and ORAI proteins are subject to redox modi-
cations and establish the consequence of these redox changes for
R Ca2+ sensing, membrane trafﬁcking, and channel gating.
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